Literature DB >> 16204271

Complement and the kidney: what the nephrologist needs to know in 2006?

Stefan P Berger, Anja Roos, Mohamed R Daha.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16204271     DOI： 10.1093/ndt/gfi166

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  21 in total

1.  Shift of C3 deposition from localization in the glomerulus into the tubulo-interstitial compartment in the absence of secreted IgM in immune complex glomerulonephritis.

Authors:  C Vaculik; B M Rüger; G Yanagida; D Hollemann; A Soleiman; U M Losert; J Chen; M B Fischer
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

2.  Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.

Authors:  Azadeh Zaferani; Romain R Vivès; Pieter van der Pol; Gerjan J Navis; Mohamed R Daha; Cees van Kooten; Hugues Lortat-Jacob; Marc A Seelen; Jacob van den Born
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

3.  Characterization of acute renal allograft rejection by proteomic analysis of renal tissue in rat.

Authors:  Gang Chen; Jing-Bin Huang; Jie Mi; Yun-Feng He; Xiao-Hou Wu; Chun-Li Luo; Si-Min Liang; Jia-Bing Li; Ya-Xiong Tang; Jie Li
Journal:  Mol Biol Rep       Date:  2011-05-22       Impact factor: 2.316

Review 4.  Pros and cons for C4d as a biomarker.

Authors:  Danielle Cohen; Robert B Colvin; Mohamed R Daha; Cinthia B Drachenberg; Mark Haas; Volker Nickeleit; Jane E Salmon; Banu Sis; Ming-Hui Zhao; Jan A Bruijn; Ingeborg M Bajema
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

5.  C1q nephropathy in children: clinical characteristics and outcome.

Authors:  Vindya N Gunasekara; Neil J Sebire; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2013-12-11       Impact factor: 3.714

6.  Circulating C3 levels predict renal and global outcome in patients with renal vasculitis.

Authors:  Javier Villacorta; Francisco Diaz-Crespo; Mercedes Acevedo; Teresa Cavero; Carmen Guerrero; Manuel Praga; Gema Fernandez-Juarez
Journal:  Clin Rheumatol       Date:  2016-08-25       Impact factor: 2.980

Review 7.  Advances and challenges in the management of complement-mediated thrombotic microangiopathies.

Authors:  Jean-Claude Davin; Nicole C A J van de Kar
Journal:  Ther Adv Hematol       Date:  2015-08

8.  Proteomic signatures in plasma during early acute renal allograft rejection.

Authors:  Gabriela V Cohen Freue; Mayu Sasaki; Anna Meredith; Oliver P Günther; Axel Bergman; Mandeep Takhar; Alice Mui; Robert F Balshaw; Raymond T Ng; Nina Opushneva; Zsuzsanna Hollander; Guiyun Li; Christoph H Borchers; Janet Wilson-McManus; Bruce M McManus; Paul A Keown; W Robert McMaster
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

Review 9.  Current status and issues of C1q nephropathy.

Authors:  Akiko Mii; Akira Shimizu; Yukinari Masuda; Emiko Fujita; Kaoru Aki; Masamichi Ishizaki; Shigeru Sato; Adam Griesemer; Yuh Fukuda
Journal:  Clin Exp Nephrol       Date:  2009-04-17       Impact factor: 2.801

10.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.